First study testing personalized medicine for Inflammatory Bowel Disease

Professor Marte Lie Høivik
Professor Marte Lie Høivik

A new study, involving researchers from UiO and OUS, will now test personalized medicine for IBD. This is a large Nordic collaboration and has received an allocation of NOK 30 million from Nordforsk.

- This is one of the first studies where we test personalized medicine in a randomized setting for IBD. That makes the study very interesting, says Professor Marte Lie Høivik.

She is a professor at UiO and senior consultant at the Department of Gastroenterology at OUS, and leads both institutions' contributions to the project.

 

Links:

Original news article from University of Oslo (in Norwegian):
Første studie som prøver ut persontilpasset medisin for IBD


Inflammatory bowel disease research group home page at OUh, led by Marte Lie Høivik

Department of Gastroenterology

Contacts:

Marte Lie Høivik, leader of the UiO and OUH contributions to the Nordtreat study

Bjørn Moum

Asle Medhus

Johannes Hov

 
Page visits: 1612